Show simple item record

Authordc.contributor.authorApt Baruch, Werner 
Admission datedc.date.accessioned2019-01-29T14:49:27Z
Available datedc.date.available2019-01-29T14:49:27Z
Publication datedc.date.issued1990
Cita de ítemdc.identifier.citationRevista medica de Chile, Volumen 118, Issue 9, 2018, Pages 1021-1027
Identifierdc.identifier.issn00349887
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/160862
Abstractdc.description.abstractNew anti-helminthic drugs have appeared lately: benzimidazoles (mebendazole, flubendazol, and abendazole), praziquantel and ivermectin. Mebendazol and flubendazol are poorly absorbed and are effective for ascaris, oxyuriasis and trycocephalus both in adults and children. Abendazole is well absorbed and may be considered the drug of choice for ascaris and oxyuriasis at a single 400 mg dose. This drug may also be used for hydatid cyst when surgery is not possible and for cysticercosis of the nervous system. Praziquantel is useful for treatment of tenia infections and ivermectin is useful for strongyloides and trichostrongyloides. Detailed dose schedules for different parasitic diseases are given in the text.
Lenguagedc.language.isoen
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceRevista medica de Chile
Keywordsdc.subjectMedicine (all)
Títulodc.titleNew anthelmintic drugs Nuevos medicamentos antihelmínticos.
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorSCOPUS
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile